Sternal-sparing redo bilateral lung transplants
It is estimated that 50% of lung transplant recipients will develop chronic lung allograft dysfunction (CLAD) to varying degrees and with various phenotypic presentations. After the first year post-transplant, CLAD is the leading cause of death for these patients and may lead to a need for retransplant. A subset of recipients with CLAD will be candidates for retransplant, and although these patients provide a unique challenge for transplant centers, optimal outcomes are achieved when morbidity and mortality are minimized by all available means.
Authors
- Caitlin T. Demarest (ORCID: https://orcid.org/0000-0001-6948-1103)
- Brandon Petree (ORCID: https://orcid.org/0000-0002-5566-028X)
- Matthew D. Bacchetta (ORCID: https://orcid.org/0000-0003-4456-4484)
- William Tucker (ORCID: https://orcid.org/0009-0003-5601-1091)
- Anil J. Trindade (ORCID: https://orcid.org/0000-0003-1399-7228)
- Sigrid Johannesen Ringenberg
- John Stokes
Institutions
- Vanderbilt University (US)
- Baylor Scott & White Health (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JTCVS Techniques
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.xjtc.2024.09.003
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cystic Fibrosis Foundation
- National Institutes of Health